Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
2.
Int J Gynaecol Obstet ; 115(3): 244-50, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21945424

RESUMEN

OBJECTIVE: To examine the quality of the maternal health system in Eritrea to understand system deficiencies and its relevance to maternal mortality within the context of Millennium Development Goal (MDG) 5. METHODS: A sample of 118 health facilities was surveyed. Data were collected on 5 dimensions of health system quality: availability; accessibility; management; infrastructure; and process indicators. Data on the causes of hospital admissions for obstetric patients and maternal deaths were extracted from medical records. RESULTS: Eritrea has only 11 comprehensive emergency obstetric care (CEmOC) facilities, all of which are grossly understaffed. There is considerable pressure on the infrastructure and health providers at hospitals. Compliance with clinical care standards and availability of supplies were optimal. As a result, the case fatality rate of 0.65% was low. In total, 45.6% of obstetric admissions and 19.5% of maternal deaths were attributed to abortion complications. CONCLUSION: In Eritrea, critical gaps in the health system-especially those related to human resources-will impede progress toward MDG 5, and it will not be possible to reduce maternal mortality without addressing the high burden of abortion.


Asunto(s)
Servicios de Salud Materna/normas , Complicaciones del Embarazo/epidemiología , Calidad de la Atención de Salud , Aborto Inducido/efectos adversos , Aborto Inducido/estadística & datos numéricos , Adulto , Servicio de Urgencia en Hospital/organización & administración , Servicio de Urgencia en Hospital/estadística & datos numéricos , Eritrea , Femenino , Adhesión a Directriz , Humanos , Servicios de Salud Materna/provisión & distribución , Mortalidad Materna , Persona de Mediana Edad , Admisión del Paciente/estadística & datos numéricos , Guías de Práctica Clínica como Asunto , Embarazo , Complicaciones del Embarazo/mortalidad , Adulto Joven
3.
J Nutr ; 134(10): 2678-84, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15465766

RESUMEN

Iron deficiency is the most common and widespread nutritional disorder in the world, affecting millions of people in both nonindustrialized and industrialized countries. We estimated the costs, effects, and cost-effectiveness of iron supplementation and iron fortification interventions in 4 regions of the world. The effects on population health were arrived at by using a population model designed to estimate the lifelong impact of iron supplementation or iron fortification on individuals benefiting from such interventions. The population model took into consideration effectiveness, patient adherence, and geographic coverage. Costs were based on primary data collection and on a review of the literature. At 95% geographic coverage, iron supplementation has a larger impact on population health than iron fortification. Iron supplementation would avert <12,500 disability adjusted life years (DALY) annually in the European subregion, with very low rates of adult and child mortality, to almost 2.5 million DALYs in the African and Southeast Asian subregions, with high rates of adult and child mortality. On the other hand, fortification is less costly than supplementation and appears to be more cost effective than iron supplementation, regardless of the geographic coverage of fortification. We conclude that iron fortification is economically more attractive than iron supplementation. However, spending the extra resources to implement iron supplementation is still a cost-effective option. The results should be interpreted with caution, because evidence of intervention effectiveness predominantly relates to small-scale efficacy trials, which may not reflect the actual effect under expected conditions.


Asunto(s)
Anemia Ferropénica , Análisis Costo-Beneficio/economía , Alimentos Fortificados/economía , Salud Global , Compuestos de Hierro/economía , Anemia Ferropénica/tratamiento farmacológico , Anemia Ferropénica/economía , Anemia Ferropénica/epidemiología , Niño , Femenino , Humanos , Compuestos de Hierro/uso terapéutico , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA